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Abstract: This paper compares three methods for estimating renal function, tested in rats.  Acute Renal 
Failure (ARF) was induced via a 60-minute bilateral renal artery clamp in 8 Sprague-Dawley rats and 
renal function was monitored for 1 week post-surgery.  A two-compartment model was developed for 
estimating renal function via a bolus injection of a radio-labelled inulin tracer, and was compared with 
the current gold standard plasma creatinine measurement, modified using the Cockcroft-Gault equation 
for rats. These two methods were compared with Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS) 
monitoring of breath analytes. Determination of renal function via SIFT-MS is desirable since results are 
available non-invasively and in real time. Relative decreases in renal function show excellent correlation 
between methods, and indicate good promise for fast, non-invasive determination of renal function via 
breath testing. 
Keywords: Renal Function, Breath Biomarkers, Integral Fitting Method, Model-based Approximation, 
Tracer Kinetics, Differential Equations. 
 
1. INTRODUCTION 
Current measurements of renal function rely on daily 
measurements of plasma creatinine. When most glomerular 
filtration function is lost, the diagnosis of kidney failure is 
delayed by up to 3 - 5 days in clinical situations. This results 
in unacceptable delays in instituting treatment. Consequently, 
there have been no improvements in mortality in the 
management of Acute Renal Failure (ARF) for over 50 years, 
despite the availability of many useful experimentally 
effective treatments. 
Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS) is an 
analytical technique for the real-time quantification of 
Volatile Organic Compounds (VOCs) in air or breath 
samples. By analyzing changes in VOC concentrations in 
breath over time, SIFT-MS can offer fast diagnosis of various 
conditions and diseases non-invasively and in real-time.   
In this study, ARF is induced in 8 Sprague-Dawley rats. 
Renal function is monitored for 1 week following induction 
of ARF via plasma creatinine measurements, SIFT-MS 
breath sampling, and radio-labelled inulin clearance tests. 
The goal is to correlate changes in breath biomarkers with the 
current clinical and model-based gold standards. 
1.1 Glomerular Filtration Rate (GFR) 
Glomerular Filtration Rate (GFR) refers to the volume of 
fluid filtered from the glomerular capillaries into Bowman’s 
Capsule of the kidney per unit time (Fig. 1), and is generally 
accepted as the best overall estimation of kidney function.  
Any substance that is freely filtered by the glomerulus and is 
not secreted or reabsorbed by the kidneys can be used to 
measure GFR. 
 
Fig. 1. Kidney Anatomy (Merriam-Webster Inc., 2006) 
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1.2 Exogenous Markers for measuring GFR 
If an exogenous filtration marker, such as inulin, is used to 
measure GFR, it is injected into the plasma, and its clearance 
through the kidney can be measured using either constant 
infusion or bolus techniques (Van Acker, et al., 1995; 
Davison, et al., 1992; Sturgeon, et al., 1998). Using the 
constant infusion technique, the exogenous marker is injected 
into the plasma at a constant rate until a steady state is 
achieved. At this point, (1) is applied, where plasma and 
timed urine samples are collected to determine the marker 
concentration (Urine Conc and Plasma Conc, µmol/L), and 
the rate of urine flow (Urine Flow, mL/min). 
ConcPlasma
FlowUrineConcUrineGFR ×=  (1) 
In practice, this technique has limitations, as it is difficult and 
slow to achieve a steady state. In contrast, bolus methods can 
be quickly carried out, and require only a single injection of 
the exogenous marker into the plasma, and serial blood 
sampling at defined intervals. Urine collection is not 
required. However, data analysis requires the application of a 
well defined mathematical model.   
1.3 Endogenous Markers for measuring GFR 
Measuring GFR via the clearance of an exogenous marker is 
time consuming, expensive, and thus not appropriate in most 
clinical settings. Hence, GFR is usually estimated using an 
endogenous marker, such as creatinine. Steady state serum 
creatinine is approximately inversely proportional to GFR. 
However, creatinine is not an ideal filtration marker because, 
in addition to being filtered by the glomerulus, it is also 
secreted by the proximal tubules, resulting in a clearance that 
exceeds GFR, particularly in ARF.  
Since creatinine generation is determined mainly via muscle 
mass and dietary intake, tubular secretion of creatinine 
depends on factors such as age, sex, race, body size and 
muscle mass, and can vary substantially between individuals 
and over time, (Davison et al. 1992). Equations such as the 
Cockcroft-Gault and the MDRD equations have been 
developed to try to correct for these limitations (Cockcroft & 
Gault 1976). Additionally, extra-renal elimination of 
creatinine via intestinal bacteria can increase at low GFR, 
thus making the method misleading for those individuals 
outside the normal range of kidney function. 
1.4 SIFT-MS Breath Sampling 
SIFT-MS is a quantitative mass spectrometric method that 
utilizes the chemical ionization of positively charged 
precursor ions that react with the VOCs in an air or breath 
sample introduced into a flow tube. Comparing the mass of 
the product ions in a database, the identity of the sample 
VOCs can be established. Changes in VOC concentration 
over time can provide an indication of disease progress. In 
this study, ammonia is the VOC of interest, since blood and 
breath ammonia increase in impaired renal function. 
2. EXPERIMENTAL METHOD 
Female Sprague-Dawley rats (280-320g, n=8) were housed at 
21oC in a 12 hour light/dark cycle, and allowed free access to 
food and water.  Under ketamine/domitor anaesthesia, an in-
dwelling cannula was inserted into the jugular vein for the 
purposes of fast serial blood sampling.  GFR was monitored 
via plasma creatinine, SIFT-MS breath sampling, and bolus 
inulin clearance for 5 days while the animal recovered from 
surgery.  In a subsequent surgery, the renal arteries were 
exposed via a single mid-ventral incision, and clamped for 60 
minutes, creating ARF via an ischemic event.  GFR was 
monitored for 7 days using the same 3 techniques, as the 
animal recovered and renal function returned to normal 
levels. The GFR monitoring schedule is shown in Table 1. 
Table 1.  GFR Monitoring Schedule 
Monitoring Time Points Method 
Post-Cannulation Post-ARF 
Plasma 
Creatinine 
6hr, 2day 1hr, 6hr, 20hr, 30hr, 
2day, 4day, 7day 
Inulin 
Clearance 
6hr, 2day 6hr, 30hr, 2day, 
4day, 7day 
SIFT-MS 
Breath 
-4hr, 1hr, 6hr, 20hr, 
30hr, 2 day, 5 day  
-4hr,1hr, 6hr, 20hr, 
30hr, 2day, 3day, 
4day,5day, 7day 
2.1 Radio-labelled Inulin Clearance 
14C labelled inulin (1 µCi of 1.12 µCi/mg dissolved in 0.1mL 
ionised water, diluted 1:4 with saline) was injected into the 
jugular vein cannula of a conscious animal over 2 seconds, 
and flushed with heparinised saline. A 150µL blood sample 
was collected via the jugular vein cannula at -1, 1.5, 3, 6, 12, 
20, 40, 70 minutes post-bolus, and sent for scintillation 
analysis. At 1 minute prior to injecting the bolus, an 
additional 150µL blood was collected for creatinine analysis. 
Red cells and remaining blood plasma were returned to the 
animal via the jugular vein after each experiment. 
2.2 Breath Sampling via SIFT-MS 
Direct breath was collected from conscious rats by wrapping 
the rat in a towel and placing it into a 300mL bottle (Fig. 2).   
 
Fig. 2. Breath Collection Apparatus 
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A background air sample was also obtained at each rat breath 
sample time-point. The tightness of the fit in the bottle 
combined with wrapping the rat in a towel minimized 
contamination from the fur and waste products.  Breathing 
holes were located posterior to the position of the rats’ nose.  
Breath was drawn directly from the bottle through the SIFT-
MS machine at 2mL/sec via a small straw attached to the end 
of the bottle. Because rats of this size have a breath flow rate 
of 2-3mL/sec, background air plays a significant role.   
3. MATHEMATICAL MODELS 
3.1 Inulin Clearance 
Injection of an inulin bolus into the blood is described by the 
2-compartment model in Fig. 3, where the bolus is injected 
into the plasma compartment, P, (with distribution volume 
VP), and moves bi-directionally to the interstitial 
compartment, Q, (distribution volume VQ), before being 
eliminated from the plasma via the kidneys. It is assumed that 
the bolus is given so quickly that the concentration in the 
interstitial compartment is initially zero. This assumption also 
indicates that the initial concentration in the plasma 
compartment is determined from the size of the injected bolus 
and the plasma volume. Hence, u(t) is set to zero. 
 
Fig. 3. Two-Compartment Model of Kidney Function 
The differential equations describing inulin in the 2 
compartments are dependent on the rate constants n1, n2, and 
n3, and the inulin mass in both compartments, p(t) and q(t).   
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Parameters n1 and n2 were identified using an iterative 
integral fitting method, (Hann et al., 2005). The assumption 
that the concentration in the interstitial compartment is 
initially zero is verified by the -1 minute blood sample.  First, 
(4) is integrated to obtain an approximation to P(t) in terms of 
the unknowns n1 and n2. A system of equations is then set up 
(6), and solved for n1 and n2 using linear least squares.  
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The initial approximation of P(t) is a linear piecewise 
approximation obtained from the measured time and 
concentration data, and P(0) is the estimated average inulin 
concentration in the plasma immediately after injection of the 
bolus, defined as the product of the bolus volume and 
concentration, divided by the estimated plasma volume of the 
animal based on its weight. Using the obtained solution for n1 
and n2, a new approximation for P(t) is generated. Constraints 
are added to the least squares solution to keep the 
approximation within known physiological ranges. Given the 
approximation for P(t), Q(t) can be solved for analytically 
using the convolution integral (7). 
 
∫
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Iterations continue until convergence is achieved.  The 
method is repeated for α values within the physiologically 
reported range of 2.2 – 4 (Levitt, 2003), until a least squares 
solution is found. The GFR is then equal to the product of n1 
and the plasma volume, where plasma volume is defined: 
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where bolus is the volume of inulin solution injected, raw_cts 
is the concentration of the injected inulin, t_bolus is the time 
over which the bolus was injected, and P(0) is the average 
inulin concentration in the plasma immediately after injecting 
the inulin bolus. 
3.2 Plasma Creatinine 
The Cockcroft-Gault equation for GRF in humans is: 
 
Cr
femaleifwtage
GFR
72
)85.0)()(140( −
=  (9) 
 
where age is patients age (years), wt is their weight (kg), and 
Cr is the plasma creatinine (µmol/L).  All animals in the 
present study are female and approximately the same age, 
therefore by plotting GFR (mL/min) values generated using 
the inulin clearance method against 
)/(
)(
LmolCr
kgwt
µ
for all rats 
at all time points, Fig. 4 and (10) are obtained, where the 
Pearson product-moment correlation coefficient (R-value) is 
0.94. 
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Fig. 4. Relationship between Creatinine, Weight and GFR 
3.3 SIFT-MS Breath Sampling 
A pilot study was conducted to determine the relationship 
between rat breath and background air in the experimental 
set-up described in Section 2.2. Healthy, conscious rats were 
allowed to equilibrate in a room containing a controlled 
concentration of ammonia. By increasing the concentration of 
the background ammonia, CB, and measuring the sample 
collected in the bottle, CTot, Fig. 5 was obtained. 
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Fig. 5. Relationship between Background and Breath in 
healthy rats 
Linear regression yields (11), where the x-intercept 
represents the concentration of the analyte in breath given a 
zero concentration in background air. The slope of CTot 
greater than 1 indicates that ammonia is concentrated in the 
breath against its concentration gradient from the blood, a 
finding that has not been previously described. 
 
5946.1 +×= BTot CC  (11) 
 
A lumped parameter model for the breath circuit is shown in 
Fig. 6. In this model, the rat is breathing at a volume flow 
rate of VR ml/sec, and breathes in and out concentrations of 
CTot and CR, respectively. SIFT-MS draws the sample at 
2mL/sec, and thus background air must be drawn into the 
bottle at 2mL/sec to maintain equilibrium. The volume flow 
rate of rat breath is calculated from tidal volume and 
respiratory rate, which for a 250-300g rat, is approximately 
2.7mL/sec (Pass and Freeth, 1993).   
 
Fig. 6. Rat Breathing Circuit 
Using continuity of mass, CR can be calculated from (12). 
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Plotting CR against CB and fitting a linear regression as in Fig. 
5 and (11), yields: 
 
10279.1 +×= BR CC  (13) 
 
Note that the CR obtained from (12) is specific to the 
background air, CB, and must be normalized to a zero 
background air concentration using (13): 
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CR* was plotted against time, following the course of each 
surgical intervention.  Hence, each rat provided their own 
control from the first surgery to ensure that it was the ARF 
and not surgery alone causing the rise in breath ammonia. 
Using this method, a percentage increase in breath ammonia 
can be reported for each rat. Alternatively, breath ammonia 
can be converted to GFR by plotting GFR obtained via inulin 
clearance against CR* for all rats at all time-points (Fig. 6). 
Hence, GFR can be estimated using breath ammonia using 
(15).  Note that domitor causes a 70% depression in 
respiration. Therefore, the ratio VB/VR increases during 
surgery and recovery from anesthesia. 
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Fig. 6. Relationship between Breath Ammonia and GFR 
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4. RESULTS AND DISCUSSION 
4.1 Bolus Radio-labelled Inulin Clearance Test 
Using the iterative integral fitting method, clearance curves 
were obtained for each rat at each time-point. Due to the 
difficulty in keeping the jugular vein cannula patent for 12 
days, some animals did not undergo the full contingent of 7 
inulin clearance tests. Fig. 7 shows a typical inulin clearance 
curve obtained for a rat in the normal and ARF states. The 
average curve fitting error was less than 10%. 
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Fig. 7 Inulin Clearance Curve 
Table 2 summarizes the inulin clearance test results. The 
maximum decrease in GFR was observed in the first 
clearance test post-ARF, at the 6 hour time-point. 
Table 2.  Inulin GFR Estimation 
Estimated GFR Rat Weight 
(g) Normal ARF 
% 
decrease  
Model 
% error 
1 299 2.60 0.95 63 8.2 
2 300 2.50 0.40 84 7.3 
3 300 2.67 0.81 70 9.1 
4 302 2.39 1.1 54 9.1 
5 291 2.74 0.91 67 8.9 
6 300 2.55 - - 12.7 
7 306 3.17 1.09 66 8.4 
8 312 2.86 0.68 76 7.3 
4.2 Plasma Creatinine  
Maximum changes in plasma creatinine concentrations were 
found to occur between 6 and 20 hours post induction of 
ARF, as indicated in Table 3. Estimated GFR values obtained 
from (10) are shown in Table 3, where the fitting factor refers 
to the constant in (10) when data is fitted in a rat-specific 
manner, as opposed to across the tested rat population. This 
deviation in fitting factor gives some indication of the 
expected error in the GFR estimation when compared to the 
inulin-clearance estimated GFR.  
Table 3. Creatinine GFR Estimation 
Estimated GFR Rat 
Normal ARF 
% 
decrease 
Fitting 
factor 
Hours to 
max. conc. 
1 2.59 1.09 58 235 6 
2 2.56 0.33 87 217 20 
3 2.69 0.90 67 222 6 
4 2.49 1.21 51 243 20 
5 2.63 0.92 65 210 6 
6 2.33 0.88 62 240 30 
7 3.25 1.05 68 207 6 
8 2.78 0.78 72 212 6 
4.3 SIFT-MS Breath Analysis  
Selected Ion Mode (SIM) scans for ammonia were performed 
on rat breath samples, and converted to GFR estimates as 
summarized in Table 4. The decreases (%) in renal function 
results show excellent correlation with the inulin estimations 
of Table 2, with a Pearson product-moment correlation 
coefficient of 0.89. 
Table 4. Breath Ammonia GFR Estimation 
Estimated GFR Rat 
Normal ARF 
% decrease Hours to max. 
conc. 
1 2.56 1.09 57 6 
2 2.75 0.42 85 20 
3 2.92 0.86 71 6 
4 2.35 1.17 50 6 
5 3.08 0.82 73 6 
6 2.94 0.71 76 6 
7 3.13 1.44 54 6 
8 2.96 0.85 71 6 
 
Error in the GFR estimation is due to the oscillation in 
ammonia concentration as recorded by the SIFT-MS, and 
seen in Fig. 8. A probably density function can be formed 
around the concentration data, to obtain the inter quartile 
range of ammonia concentration. Because of the similar 
flowrates between breath and machine sampling, the error is 
effectively amplified in the current study when CTot and CB 
are combined to obtain CR.  However, with the introduction 
of a new Voice200® SIFT-MS machine which samples at the 
lower rate of 2mL/min (as opposed to 2mL/sec), this error 
could be minimized in future studies. 
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Fig. 8. Oscillation in Ammonia SIM Scan 
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4.4 Comparison in GFR Estimations  
Excellent correlation is observed between the percentage 
decreases in renal function estimated by the 3 different 
methods. When the population metrics are combined for the 
plasma creatinine and breath ammonia data to obtain GFR 
estimates, Figs. 9-11 are obtained for a selection of the 
animals.  
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Fig. 9. Rat 1 GFR Comparision 
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Fig. 10. Rat 4 GFR Comparision 
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Fig. 11. Rat 7 GFR Comparision 
Figures 9-11 show the time-course for GFR estimation via 
the 3 methods. An initial decrease in GFR is caused by 
surgery alone, and the second, larger decrease in GFR is due 
to the ARF. Error bars indicate the variability of SIFT-MS. 
Better technology with the Voice200®, and filtering of 
multiple samples would reduce this error and further improve 
correlations. 
5. CONCLUSIONS 
ARF was induced in 8 rats, and the degree of renal failure 
was estimated using 3 different methods: bolus radio-labelled 
inulin clearance test, plasma creatinine measurement, and 
SIFT-MS breath analyte monitoring. The relative decrease in 
function is the most useful metric, for which the Pearson 
product-moment correlation coefficient was 0.89 between 
breath and inulin techniques. However, a population model 
for absolute GFR estimation was also able to be generated 
from creatinine and breath data with very good correlations 
observed in Figures 9-11.  
It was found in a pilot study (Figure 5), that the concentration 
of expired ammonia increases as a function of background 
ammonia concentration with a slope greater than 1. This 
result indicates that ammonia can be removed from the body 
at a concentration greater than that possible by simple 
diffusion from the blood, alone, suggesting the presence of 
ammonia transporters in lung epithelium for actively 
transporting ammonia. 
Determination of renal function via SIFT-MS is desirable 
since results are available non-invasively and in real time. 
Correlation between relative decreases in renal function 
presented here, indicate good promise for fast, non-invasive 
determination of renal function via breath testing. 
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